Global Oocyte Cryopreservation Market Analysis and Forecast 2024-2030

Global Oocyte Cryopreservation Market Analysis and Forecast 2024-2030


Summary

According to APO Research, The global Oocyte Cryopreservation market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oocyte Cryopreservation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Oocyte Cryopreservation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Oocyte Cryopreservation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Oocyte Cryopreservation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Oocyte Cryopreservation include Prelude Fertility, CReATe Fertility Center, Anova Fertility, San Diego Fertility Center (SDFC), Extend Fertility, Shady Grove Fertility, Mayo Clinic, Reproductive Biology Associates and CCRM IVF, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Oocyte Cryopreservation, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Oocyte Cryopreservation, also provides the revenue of main regions and countries. Of the upcoming market potential for Oocyte Cryopreservation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oocyte Cryopreservation revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oocyte Cryopreservation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oocyte Cryopreservation revenue, projected growth trends, production technology, application and end-user industry.

Oocyte Cryopreservation segment by Company

Prelude Fertility
CReATe Fertility Center
Anova Fertility
San Diego Fertility Center (SDFC)
Extend Fertility
Shady Grove Fertility
Mayo Clinic
Reproductive Biology Associates
CCRM IVF
HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
Kindbody
West Coast Fertility Centers
Oocyte Cryopreservation segment by Type

Slow-cooling Method
Flash-freezing Process (Vitrification)
Oocyte Cryopreservation segment by Customer
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
Oocyte Cryopreservation segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oocyte Cryopreservation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oocyte Cryopreservation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oocyte Cryopreservation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Oocyte Cryopreservation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Oocyte Cryopreservation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oocyte Cryopreservation revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Oocyte Cryopreservation Market by Type
1.2.1 Global Oocyte Cryopreservation Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Slow-cooling Method
1.2.3 Flash-freezing Process (Vitrification)
1.3 Oocyte Cryopreservation Market by Customer
1.3.1 Global Oocyte Cryopreservation Market Size by Customer, 2019 VS 2023 VS 2030
1.3.2 25-30 Year Old Female
1.3.3 30-35 Year Old Female
1.3.4 35-40 Year Old Female
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Oocyte Cryopreservation Market Dynamics
2.1 Oocyte Cryopreservation Industry Trends
2.2 Oocyte Cryopreservation Industry Drivers
2.3 Oocyte Cryopreservation Industry Opportunities and Challenges
2.4 Oocyte Cryopreservation Industry Restraints
3 Global Growth Perspective
3.1 Global Oocyte Cryopreservation Market Perspective (2019-2030)
3.2 Global Oocyte Cryopreservation Growth Trends by Region
3.2.1 Global Oocyte Cryopreservation Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Oocyte Cryopreservation Market Size by Region (2019-2024)
3.2.3 Global Oocyte Cryopreservation Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Oocyte Cryopreservation Revenue by Players
4.1.1 Global Oocyte Cryopreservation Revenue by Players (2019-2024)
4.1.2 Global Oocyte Cryopreservation Revenue Market Share by Players (2019-2024)
4.1.3 Global Oocyte Cryopreservation Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Oocyte Cryopreservation Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Oocyte Cryopreservation Key Players Headquarters & Area Served
4.4 Global Oocyte Cryopreservation Players, Product Type & Application
4.5 Global Oocyte Cryopreservation Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Oocyte Cryopreservation Market CR5 and HHI
4.6.2 Global Top 5 and 10 Oocyte Cryopreservation Players Market Share by Revenue in 2023
4.6.3 2023 Oocyte Cryopreservation Tier 1, Tier 2, and Tier 3
5 Oocyte Cryopreservation Market Size by Type
5.1 Global Oocyte Cryopreservation Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Oocyte Cryopreservation Revenue by Type (2019-2030)
5.3 Global Oocyte Cryopreservation Revenue Market Share by Type (2019-2030)
6 Oocyte Cryopreservation Market Size by Application
6.1 Global Oocyte Cryopreservation Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Oocyte Cryopreservation Revenue by Application (2019-2030)
6.3 Global Oocyte Cryopreservation Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Prelude Fertility
7.1.1 Prelude Fertility Comapny Information
7.1.2 Prelude Fertility Business Overview
7.1.3 Prelude Fertility Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.1.4 Prelude Fertility Oocyte Cryopreservation Product Portfolio
7.1.5 Prelude Fertility Recent Developments
7.2 CReATe Fertility Center
7.2.1 CReATe Fertility Center Comapny Information
7.2.2 CReATe Fertility Center Business Overview
7.2.3 CReATe Fertility Center Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.2.4 CReATe Fertility Center Oocyte Cryopreservation Product Portfolio
7.2.5 CReATe Fertility Center Recent Developments
7.3 Anova Fertility
7.3.1 Anova Fertility Comapny Information
7.3.2 Anova Fertility Business Overview
7.3.3 Anova Fertility Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.3.4 Anova Fertility Oocyte Cryopreservation Product Portfolio
7.3.5 Anova Fertility Recent Developments
7.4 San Diego Fertility Center (SDFC)
7.4.1 San Diego Fertility Center (SDFC) Comapny Information
7.4.2 San Diego Fertility Center (SDFC) Business Overview
7.4.3 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.4.4 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Product Portfolio
7.4.5 San Diego Fertility Center (SDFC) Recent Developments
7.5 Extend Fertility
7.5.1 Extend Fertility Comapny Information
7.5.2 Extend Fertility Business Overview
7.5.3 Extend Fertility Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.5.4 Extend Fertility Oocyte Cryopreservation Product Portfolio
7.5.5 Extend Fertility Recent Developments
7.6 Shady Grove Fertility
7.6.1 Shady Grove Fertility Comapny Information
7.6.2 Shady Grove Fertility Business Overview
7.6.3 Shady Grove Fertility Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.6.4 Shady Grove Fertility Oocyte Cryopreservation Product Portfolio
7.6.5 Shady Grove Fertility Recent Developments
7.7 Mayo Clinic
7.7.1 Mayo Clinic Comapny Information
7.7.2 Mayo Clinic Business Overview
7.7.3 Mayo Clinic Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.7.4 Mayo Clinic Oocyte Cryopreservation Product Portfolio
7.7.5 Mayo Clinic Recent Developments
7.8 Reproductive Biology Associates
7.8.1 Reproductive Biology Associates Comapny Information
7.8.2 Reproductive Biology Associates Business Overview
7.8.3 Reproductive Biology Associates Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.8.4 Reproductive Biology Associates Oocyte Cryopreservation Product Portfolio
7.8.5 Reproductive Biology Associates Recent Developments
7.9 CCRM IVF
7.9.1 CCRM IVF Comapny Information
7.9.2 CCRM IVF Business Overview
7.9.3 CCRM IVF Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.9.4 CCRM IVF Oocyte Cryopreservation Product Portfolio
7.9.5 CCRM IVF Recent Developments
7.10 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
7.10.1 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Comapny Information
7.10.2 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Business Overview
7.10.3 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.10.4 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Product Portfolio
7.10.5 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Recent Developments
7.11 Kindbody
7.11.1 Kindbody Comapny Information
7.11.2 Kindbody Business Overview
7.11.3 Kindbody Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.11.4 Kindbody Oocyte Cryopreservation Product Portfolio
7.11.5 Kindbody Recent Developments
7.12 West Coast Fertility Centers
7.12.1 West Coast Fertility Centers Comapny Information
7.12.2 West Coast Fertility Centers Business Overview
7.12.3 West Coast Fertility Centers Oocyte Cryopreservation Revenue and Gross Margin (2019-2024)
7.12.4 West Coast Fertility Centers Oocyte Cryopreservation Product Portfolio
7.12.5 West Coast Fertility Centers Recent Developments
8 North America
8.1 North America Oocyte Cryopreservation Revenue (2019-2030)
8.2 North America Oocyte Cryopreservation Revenue by Type (2019-2030)
8.2.1 North America Oocyte Cryopreservation Revenue by Type (2019-2024)
8.2.2 North America Oocyte Cryopreservation Revenue by Type (2025-2030)
8.3 North America Oocyte Cryopreservation Revenue Share by Type (2019-2030)
8.4 North America Oocyte Cryopreservation Revenue by Customer (2019-2030)
8.4.1 North America Oocyte Cryopreservation Revenue by Customer (2019-2024)
8.4.2 North America Oocyte Cryopreservation Revenue by Customer (2025-2030)
8.5 North America Oocyte Cryopreservation Revenue Share by Customer (2019-2030)
8.6 North America Oocyte Cryopreservation Revenue by Country
8.6.1 North America Oocyte Cryopreservation Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Oocyte Cryopreservation Revenue by Country (2019-2024)
8.6.3 North America Oocyte Cryopreservation Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Oocyte Cryopreservation Revenue (2019-2030)
9.2 Europe Oocyte Cryopreservation Revenue by Type (2019-2030)
9.2.1 Europe Oocyte Cryopreservation Revenue by Type (2019-2024)
9.2.2 Europe Oocyte Cryopreservation Revenue by Type (2025-2030)
9.3 Europe Oocyte Cryopreservation Revenue Share by Type (2019-2030)
9.4 Europe Oocyte Cryopreservation Revenue by Customer (2019-2030)
9.4.1 Europe Oocyte Cryopreservation Revenue by Customer (2019-2024)
9.4.2 Europe Oocyte Cryopreservation Revenue by Customer (2025-2030)
9.5 Europe Oocyte Cryopreservation Revenue Share by Customer (2019-2030)
9.6 Europe Oocyte Cryopreservation Revenue by Country
9.6.1 Europe Oocyte Cryopreservation Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Oocyte Cryopreservation Revenue by Country (2019-2024)
9.6.3 Europe Oocyte Cryopreservation Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Oocyte Cryopreservation Revenue (2019-2030)
10.2 China Oocyte Cryopreservation Revenue by Type (2019-2030)
10.2.1 China Oocyte Cryopreservation Revenue by Type (2019-2024)
10.2.2 China Oocyte Cryopreservation Revenue by Type (2025-2030)
10.3 China Oocyte Cryopreservation Revenue Share by Type (2019-2030)
10.4 China Oocyte Cryopreservation Revenue by Customer (2019-2030)
10.4.1 China Oocyte Cryopreservation Revenue by Customer (2019-2024)
10.4.2 China Oocyte Cryopreservation Revenue by Customer (2025-2030)
10.5 China Oocyte Cryopreservation Revenue Share by Customer (2019-2030)
11 Asia (Excluding China)
11.1 Asia Oocyte Cryopreservation Revenue (2019-2030)
11.2 Asia Oocyte Cryopreservation Revenue by Type (2019-2030)
11.2.1 Asia Oocyte Cryopreservation Revenue by Type (2019-2024)
11.2.2 Asia Oocyte Cryopreservation Revenue by Type (2025-2030)
11.3 Asia Oocyte Cryopreservation Revenue Share by Type (2019-2030)
11.4 Asia Oocyte Cryopreservation Revenue by Customer (2019-2030)
11.4.1 Asia Oocyte Cryopreservation Revenue by Customer (2019-2024)
11.4.2 Asia Oocyte Cryopreservation Revenue by Customer (2025-2030)
11.5 Asia Oocyte Cryopreservation Revenue Share by Customer (2019-2030)
11.6 Asia Oocyte Cryopreservation Revenue by Country
11.6.1 Asia Oocyte Cryopreservation Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Oocyte Cryopreservation Revenue by Country (2019-2024)
11.6.3 Asia Oocyte Cryopreservation Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Oocyte Cryopreservation Revenue (2019-2030)
12.2 MEALA Oocyte Cryopreservation Revenue by Type (2019-2030)
12.2.1 MEALA Oocyte Cryopreservation Revenue by Type (2019-2024)
12.2.2 MEALA Oocyte Cryopreservation Revenue by Type (2025-2030)
12.3 MEALA Oocyte Cryopreservation Revenue Share by Type (2019-2030)
12.4 MEALA Oocyte Cryopreservation Revenue by Customer (2019-2030)
12.4.1 MEALA Oocyte Cryopreservation Revenue by Customer (2019-2024)
12.4.2 MEALA Oocyte Cryopreservation Revenue by Customer (2025-2030)
12.5 MEALA Oocyte Cryopreservation Revenue Share by Customer (2019-2030)
12.6 MEALA Oocyte Cryopreservation Revenue by Country
12.6.1 MEALA Oocyte Cryopreservation Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Oocyte Cryopreservation Revenue by Country (2019-2024)
12.6.3 MEALA Oocyte Cryopreservation Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings